Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Animal Cell Therapies Announces $1.5 million Developmental Work in Canine Orthopedic Product LineAnimal Cell Therapies makes a $1.5 million commitment to developing their proprietary canine orthopedice product line.
"This type of financial commitment demonstrates that we are dedicated to propelling innovation and providing solutions for veterinarians, pets and pet owners,” said Dr. Kathy Petrucci, Chief Medical Officer of Animal Cell Therapies. The dedicated funds will allow Animal Cell Therapies, in partnership with leading researchers, to fully develop the PROTECT Cell Therapy product portfolio. The portfolio will include a proprietary cell processing procedure, patented materials, precise protocols and an all-inclusive operating system. “We believe R&D capital allocated to strategic partnerships is a necessary step towards commercialization.” About Animal Cell Therapies Founded in January 2009 in San Diego, California, Animal Cell Therapies (ACT) is the manifestation of veterinarian, Dr. Kathryn Petrucci, whose vision is to improve the lives of animals through thoughtful research and development, innovation and strategic partnerships. At the Company’s California-based stem cell research and development facility, the ACT team is focused on developing and delivering revolutionary cellular treatment and services to their customers. For more information, visit www.actcells.com. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|